ConductScience.org, home

Paper20009104

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.

Guo D and 25 others. Sci Signal, 2009. Cited by 298 papers, by iCite.

Cite this record

ConductScience Library. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Papers, record 20009104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20009104

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
PubMed
Journal
Sci Signal
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
298
iCite
Relative citation ratio, by iCite
6.03
iCite
Revised in PubMed
2025-05-29
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo DDeliang
2Prins RMRobert M
3Dang JJulie
4Kuga DDaisuke
5Iwanami AAkio
6Soto HHoracio
7Lin KYKelly Y
8Huang TTTiffany T
9Akhavan DDavid
10Hock MBM Benjamin
11Zhu SShaojun
12Kofman AAAva A
13Bensinger SJSteve J
14Yong WHWilliam H
15Vinters HVHarry V
16Horvath SSteve
17Watson ADAndrew D
18Kuhn JGJohn G
19Robins HIH Ian
20Mehta MPMinesh P

Source PubMed

See all 26 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Brain NeoplasmsMajor topic
ErbB ReceptorsMajor topic
GlioblastomaMajor topic
LipogenesisMajor topic
Proto-Oncogene Proteins c-aktMajor topic
QuinazolinesMajor topic
Signal TransductionMajor topic
SirolimusMajor topic
Sterol Regulatory Element Binding Protein 1Major topic
Fatty Acids
Gene Knockdown Techniques
Humans
Hydrolysis
Lapatinib
Phosphatidylinositol 3-Kinases
Protein Transport

Source PubMed

Download CSV of topics

Grants25

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA108633NCI NIH HHSUnited StatesR01CA108633PubMed and NIHNIH RePORTER
M01-RR03186NCRR NIH HHSUnited StatesM01RR003186PubMed and NIHNIH RePORTER
R01 NS050151NINDS NIH HHSUnited StatesR01NS050151PubMed and NIHNIH RePORTER
P30CA54174NCI NIH HHSUnited StatesP30CA054174PubMed and NIHNIH RePORTER
NS050151NINDS NIH HHSUnited StatesR01NS050151PubMed and NIHNIH RePORTER
CA16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
U54 CA119347NCI NIH HHSUnited StatesU54CA119347PubMed and NIHNIH RePORTER
U01 CA062399NCI NIH HHSUnited StatesU01CA062399PubMed and NIHNIH RePORTER
U01 CA062421NCI NIH HHSUnited StatesU01CA062421PubMed and NIHNIH RePORTER
U01 CA062422NCI NIH HHSUnited StatesU01CA062422PubMed and NIHNIH RePORTER
CA62412NCI NIH HHSUnited StatesU01CA062412PubMed and NIHNIH RePORTER
U01 CA062407NCI NIH HHSUnited StatesU01CA062407PubMed and NIHNIH RePORTER
U01 CA062426NCI NIH HHSUnited StatesU01CA062426PubMed and NIHNIH RePORTER
M01 RR000079NCRR NIH HHSUnited StatesM01RR000079PubMed and NIHNIH RePORTER
M01 RR000056NCRR NIH HHSUnited StatesM01RR000056PubMed and NIHNIH RePORTER
M01-RR00079NCRR NIH HHSUnited StatesM01RR000079PubMed and NIHNIH RePORTER
R01 CA108633NCI NIH HHSUnited StatesR01CA108633PubMed and NIHNIH RePORTER
U01CA62422NCI NIH HHSUnited StatesU01CA062422PubMed and NIHNIH RePORTER
M01-RR00056NCRR NIH HHSUnited StatesM01RR000056PubMed and NIHNIH RePORTER
CA 62404NCI NIH HHSUnited StatesPubMedPubMed

See all 25 grantsDownload CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118455118A sweet new role for EGFR in cancer.Cancer Cell2008https://conductscience.org/library/papers/18455118PubMed
218215105Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.PLoS Med2008https://conductscience.org/library/papers/18215105PubMed
38895767A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.Cancer Res1996https://conductscience.org/library/papers/8895767PubMed
417872411Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies.Science2007https://conductscience.org/library/papers/17872411PubMed
515956649Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.J Natl Cancer Inst2005https://conductscience.org/library/papers/15956649PubMed
618325754Acquired resistance to tyrosine kinase inhibitors during cancer therapy.Curr Opin Genet Dev2008https://conductscience.org/library/papers/18325754PubMed
714638850Phase II trial of gefitinib in recurrent glioblastoma.J Clin Oncol2004https://conductscience.org/library/papers/14638850PubMed
818568074Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.J Clin Invest2008https://conductscience.org/library/papers/18568074PubMed
912782577Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.Cancer Res2003https://conductscience.org/library/papers/12782577PubMed
1018772890Comprehensive genomic characterization defines human glioblastoma genes and core pathways.Nature2008https://conductscience.org/library/papers/18772890PubMed
1116282176Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.N Engl J Med2005https://conductscience.org/library/papers/16282176PubMed
1218382725From fatty streak to fatty liver: 33 years of joint publications in the JCI.J Clin Invest2008https://conductscience.org/library/papers/18382725PubMed
1315758009Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med2005https://conductscience.org/library/papers/15758009PubMed
149235933Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1.J Biol Chem1997https://conductscience.org/library/papers/9235933PubMed
1517046224Glucose metabolism and cancer.Curr Opin Cell Biol2006https://conductscience.org/library/papers/17046224PubMed
167958866Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2.Genes Dev1994https://conductscience.org/library/papers/7958866PubMed
1718177721The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab2008https://conductscience.org/library/papers/18177721PubMed
1811057895Cell signaling by receptor tyrosine kinases.Cell2000https://conductscience.org/library/papers/11057895PubMed
1919625624The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19625624PubMed
2018455122Survival of cancer cells is maintained by EGFR independent of its kinase activity.Cancer Cell2008https://conductscience.org/library/papers/18455122PubMed

See all 37 referencesDownload CSV of references

Cited by235

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 298 citations.

PMIDTitleJournalYearIn PapersSource
42958602Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation.Exp Hematol Oncol2026https://conductscience.org/library/papers/42958602PubMed
42942857BH3 Profiling Identifies Apoptotic Priming by SREBP-1/-2 Inhibition and Synergistic Anti-Glioblastoma Activity When Combined with ABT-263 In Vitro.Pharmaceutics2026https://conductscience.org/library/papers/42942857PubMed
42649887Fatty Acid Metabolism Rewires Glioblastoma Progression and Treg-Mediated Immune Resistance.Cancers (Basel)2026https://conductscience.org/library/papers/42649887PubMed
42613451The interplay between lipid metabolism, cancer progression and anti-cancer immunity.Exp Mol Med2026https://conductscience.org/library/papers/42613451PubMed
42220493Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes.Front Immunol2026https://conductscience.org/library/papers/42220493PubMed
42009969Thr3/Ser90 phosphorylation-stabilized S100A8 regulates cholesterol metabolism in glioblastoma stem cells.Oncogene2026https://conductscience.org/library/papers/42009969PubMed
41971814Targeting fatty acid metabolism for cancer therapy.Fundam Res2026https://conductscience.org/library/papers/41971814PubMed
41838210GPR40 Attenuates Glioma TMZ-Resistance Through Ferroptosis Inhibition.Neurochem Res2026https://conductscience.org/library/papers/41838210PubMed
41820632Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development.Cancer Metastasis Rev2026https://conductscience.org/library/papers/41820632PubMed
41732157Clinical significance and oncogenic role of ECHDC2 in glioblastoma: a comprehensive analysis based on bioinformatics and in vitro experiments.Front Genet2026https://conductscience.org/library/papers/41732157PubMed
41663272Metabolic permissiveness: how tissue context shapes cancer.Genes Dev2026https://conductscience.org/library/papers/41663272PubMed
41569525Lipids regulate epidermal growth factor receptor activation by its ligands.Biochem Soc Trans2026https://conductscience.org/library/papers/41569525PubMed
41057350Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma.Cell Death Dis2025https://conductscience.org/library/papers/41057350PubMed
40931220Exploring Differentially Expressed Genes and Understanding the Underlying Mechanisms in Glioblastoma.Biochem Genet2026https://conductscience.org/library/papers/40931220PubMed
40855015BRI3 Orchestrates Lipid Metabolism and Autophagy in Glioblastoma: Implications for Tumor Cell Resilience.Biochem Genet2026https://conductscience.org/library/papers/40855015PubMed
40814339Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges.Innovation (Camb)2025https://conductscience.org/library/papers/40814339PubMed
40628732Glioblastoma at the crossroads: current understanding and future therapeutic horizons.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40628732PubMed
40539068Targeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40539068PubMed
40454501Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors.Curr Pharm Des2025https://conductscience.org/library/papers/40454501PubMed
40249802Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth.Sci Adv2025https://conductscience.org/library/papers/40249802PubMed

See all 235 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20009104

GET https://conductscience.org/api/papers/v1/20009104/authors?page=2